VC Funds Starting with I

IT-Translation is a Paris-based venture capital firm founded in 2011, specializing in early-stage investments in digital technology startups that emerge from public and private research. The firm plays a unique dual role as both an investor and co-founder, providing not just financial backing but also operational support to help transform innovative research into marketable products and services. IT-Translation typically invests up to €300,000 in the earliest stages of a startup, often co-founding the company alongside researchers. This approach is deeply collaborative, with IT-Translation taking a hands-on role in guiding startups through product development, market entry, and scaling. The firm holds an initial 15% equity stake, which can increase up to 30% through subsequent investment rounds. Their model is particularly focused on leveraging the technological potential of French research to create high-value companies capable of leading in the digital space. The firm’s investments are rooted in their commitment to fostering innovation and supporting the growth of the French tech ecosystem. Their portfolio spans a diverse range of sectors within digital technology, from AI to cybersecurity, demonstrating their broad impact across the industry. By aligning their financial investments with strategic support, IT-Translation has established itself as a key player in the early-stage deep tech ecosystem in France.

Iter Investments is a venture capital firm headquartered in Fort Lauderdale, Florida, focusing on early-stage companies within the psychedelic industry. Established in 2021 by Dustin Robinson and Robert Velarde, the firm aims to transform the mental and behavioral health sector by supporting innovative companies leveraging psychedelics for therapeutic purposes. Iter Investments raised over $20 million for its inaugural fund, which it uses to back ventures across the psychedelic value chain, from drug development and clinics to technology and digital therapeutics. The firm’s portfolio includes companies like Psilera, Beckley Psytech, and Awakn Life Sciences, which work on developing treatments for conditions such as depression, PTSD, and addiction. Iter also invests in supporting infrastructure, such as Psygen, a supplier of psychedelic ingredients, and Tripp, which integrates virtual reality with psychedelic science for therapeutic applications. Furthermore, they have established Nucleus, a holding company for media and data assets, to help expand their reach across the industry ecosystem. The team at Iter consists of experts across law, science, and healthcare, ensuring robust due diligence and strategic support for their portfolio companies. By leading funding rounds and taking board seats, Iter Investments provides not only capital but also guidance to navigate the complex regulatory and commercial landscape. Their holistic approach aims to bridge the gap between groundbreaking research and widespread commercialization, ensuring that advancements in psychedelic therapies can effectively reach the market.

ITIC (Industrial Technology Investment Corporation) is a venture capital arm of Taiwan's Industrial Technology Research Institute (ITRI), founded in 1979. Over the years, ITIC has invested more than $400 million across a wide range of sectors, including semiconductors, biotech, precision machinery, and automotive technologies. The firm focuses on both early and growth-stage investments, leveraging the vast technical expertise and resources of ITRI, which includes over 6,000 researchers and 25,000 patents. What sets ITIC apart is its deep involvement in R&D and the global ecosystem of partnerships it has built over four decades, connecting startups with manufacturers, market intelligence, and corporate partners. Some of its notable portfolio companies include UMC and AUO. ITIC also manages various funds, such as the Golden Asia Fund and the Digital Economy Fund, targeting emerging tech trends like AI, IoT, and advanced materials. ITIC’s CVC (Corporate Venture Capital) program helps established companies invest in startups that align with their strategic goals, reducing risks through expert guidance and post-investment support.

IVP (Institutional Venture Partners) is a premier later-stage venture capital and growth equity firm founded in 1980. With a strong track record of investing in over 400 companies and achieving 130 IPOs, IVP specializes in venture growth investments, founder liquidity transactions, and select public market investments. Notable companies in IVP’s portfolio include Snapchat, Discord, Coinbase, Brex, Grammarly, Robinhood, and Slack. IVP has been instrumental in the growth and success of these firms, often leading late-stage funding rounds with substantial investments ranging from $10 to $100 million. Recent successful IPOs under IVP's guidance include companies like Compass, CrowdStrike, Datadog, Hims & Hers, Sumo Logic, and UiPath. IVP operates from its headquarters in Menlo Park, California, and has recently expanded its presence to London, establishing a bridge to support the growing tech ecosystem in Europe. This move is aimed at partnering with European entrepreneurs and tech companies in AI, fintech, cybersecurity, and enterprise infrastructure. The firm is led by experienced partners such as Tom Loverro, who has been pivotal in investments in companies like Coinbase, and Alex Lim, who played a key role in partnerships with UiPath and Discord. IVP's investment philosophy emphasizes building long-term relationships with high-growth companies and providing strategic support to help them scale efficiently. For startups looking to engage with IVP, it is essential to demonstrate strong growth potential and a clear path to market leadership. The firm values deep industry knowledge, innovative solutions, and the ability to achieve significant market impact.